Clinica San Camilo, Argentina Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04530578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CLINICA SAN CAMILO | Clinica San Camilo, Argentina

Active Ingredients

Drugs in Phase 4 Trials (2)

enoxaparin (lovenox) (1 trial)

heparin (liquaemin) (1 trial)

Drugs in Phase 3 Trials (1)

unfractionated heparin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 4)

Pneumonia (Phase 4)

Severe Acute Respiratory Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3